Key facts
- STATE STREET CORP filed SCHEDULE 13G for KRYSTAL BIOTECH INC COMMON STOCK (KRYS).
- Disclosed ownership: 4.4%.
- Date of event: 31 Dec 2024.
STATE STREET CORP - 31 Dec 2024 SCHEDULE 13G Report for KRYSTAL BIOTECH INC COMMON STOCK (KRYS)
- Filing Manager
- STATE STREET CORP
- Reporting Manager
- STATE STREET CORPORATION
- Security
- KRYSTAL BIOTECH INC COMMON STOCK
- Symbol
- KRYS
- Shares outstanding
- 29,067,614 shares
- Disclosed Ownership
- 1,278,975 shares
- Ownership
- 4.4%
- Form type
- SCHEDULE 13G
- Filing time
- 05 Feb 2025, 07:51:21 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Key filing fact
STATE STREET CORP disclosed 4.4% ownership in KRYSTAL BIOTECH INC COMMON STOCK (KRYS) on 31 Dec 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Feb 2025, 07:51.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| STATE STREET CORPORATION | 4.4% | 1,278,975 | 0 | 1,183,811 | ELIZABETH SCHAEFER | SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER |
CIK / CUSIP context first